One of such studies by Witek et al. (2016) examined gene expression profiles in endometrial cancer and revealed that BAK1 is overexpressed in grade 3 endometrial cancer which suggests that the tumor suppression system is still active and has yet to fulfil its role (Witek et al., 2016). This evidence concerns the gene BAK1 and neoplasm.